罗欣药业
(002793)
| 流通市值：47.78亿 | | | 总市值：47.85亿 |
| 流通股本：10.86亿 | | | 总股本：10.88亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 682,812,040.73 | 898,312,952.49 | 723,870,325.69 | 692,899,478.54 |
| 应收票据及应收账款 | 464,946,941.39 | 445,937,122.41 | 491,848,005.41 | 504,542,381.19 |
| 应收账款 | 464,946,941.39 | 445,937,122.41 | 491,848,005.41 | 504,542,381.19 |
| 应收款项融资 | 10,955,682.2 | 34,642,641.66 | 50,633,415.99 | 94,345,830.66 |
| 预付款项 | 106,552,263.4 | 166,960,057.25 | 127,491,628.3 | 36,421,496.98 |
| 其他应收款合计 | 104,217,674.39 | 105,491,479.93 | 132,504,239.93 | 115,710,762.78 |
| 存货 | 535,298,326.98 | 522,796,634.8 | 419,729,072.59 | 455,611,306.5 |
| 一年内到期的非流动资产 | 82,992,000 | 82,992,000 | 82,992,000 | 82,992,000 |
| 其他流动资产 | 53,837,856.1 | 67,789,763.05 | 61,437,274.77 | 57,874,315.72 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,043,712,785.19 | 2,348,157,159.16 | 2,111,895,131.73 | 2,067,511,343.63 |
| 非流动资产: | | | | |
| 长期应收款 | 45,014,347.47 | 45,014,347.47 | 124,488,000 | 124,488,000 |
| 长期股权投资 | 172,186,361.26 | 177,857,786.59 | 181,575,333.85 | 184,634,863.54 |
| 其他权益工具投资 | 60,839,905.03 | 61,876,564.09 | 61,600,468.96 | 60,426,243.02 |
| 其他非流动金融资产 | 1,250,336.22 | - | - | - |
| 固定资产 | 1,436,116,227.6 | 1,168,842,746.59 | 1,207,044,865.89 | 1,247,031,660.68 |
| 在建工程 | 44,859,687.81 | 363,209,813.25 | 341,073,650.28 | 336,860,300.86 |
| 使用权资产 | 37,711,096.21 | 39,316,196.91 | 42,263,262.03 | 45,657,468.33 |
| 无形资产 | 470,508,653.75 | 457,031,892.4 | 466,520,362.31 | 476,240,441.56 |
| 开发支出 | 256,741,195.4 | 250,340,728.25 | 232,668,250.08 | 224,910,329.08 |
| 商誉 | 1,953,023.99 | 1,953,023.99 | 1,953,023.99 | 1,953,023.99 |
| 长期待摊费用 | 16,879,602.7 | 18,419,291 | 19,711,652.92 | 19,258,213.13 |
| 递延所得税资产 | 261,466,371.01 | 279,262,103.47 | 284,103,990.91 | 286,150,240.48 |
| 其他非流动资产 | 40,037,713.2 | 42,285,204.52 | 42,285,204.52 | 42,285,204.52 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,845,564,521.65 | 2,905,409,698.53 | 3,005,288,065.74 | 3,049,895,989.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,889,277,306.84 | 5,253,566,857.69 | 5,117,183,197.47 | 5,117,407,332.82 |
| 流动负债: | | | | |
| 短期借款 | 946,486,153.68 | 1,072,884,764.28 | 803,152,286.41 | 555,602,953.75 |
| 交易性金融负债 | 4,046,892.28 | 4,046,892.28 | 4,046,892.28 | 4,046,892.28 |
| 应付票据及应付账款 | 456,283,094.43 | 469,023,143.96 | 398,899,450 | 384,893,507.79 |
| 其中：应付票据 | 7,304,868 | - | - | - |
| 应付账款 | 448,978,226.43 | 469,023,143.96 | 398,899,450 | 384,893,507.79 |
| 合同负债 | 86,056,047.64 | 107,958,210.69 | 131,280,057.14 | 134,281,640.76 |
| 应付职工薪酬 | 57,961,910.18 | 51,281,924.62 | 97,230,795.59 | 110,186,751.73 |
| 应交税费 | 13,322,634.41 | 13,247,583.57 | 19,321,497.03 | 15,413,754.61 |
| 其他应付款合计 | 98,845,283.8 | 107,500,435.77 | 123,818,595.08 | 223,475,839.38 |
| 应付股利 | 1,270,308.27 | 1,270,308.27 | 1,270,308.27 | 1,270,308.27 |
| 一年内到期的非流动负债 | 734,268,647.43 | 726,575,620.51 | 648,524,846.36 | 469,377,168.59 |
| 其他流动负债 | 9,562,286.19 | 11,920,063.76 | 12,869,936.37 | 8,990,056.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,406,832,950.04 | 2,571,102,955.88 | 2,247,538,366.55 | 1,917,555,795.86 |
| 非流动负债: | | | | |
| 长期借款 | 171,786,862.39 | 171,037,146.75 | 250,750,903.64 | 429,232,204.34 |
| 租赁负债 | 32,771,470.9 | 33,131,124.99 | 37,946,345.22 | 39,073,896.73 |
| 长期应付款 | - | - | 27,511,146.18 | 27,019,429.07 |
| 预计负债 | 35,840,938.94 | 34,708,100.12 | 34,945,362.34 | 34,597,507.88 |
| 递延收益 | 81,790,825.74 | 84,560,526.26 | 87,179,739.89 | 89,934,443.54 |
| 递延所得税负债 | 6,212,088.32 | 6,797,559.63 | 7,214,989.54 | 7,584,734.92 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 328,402,186.29 | 330,234,457.75 | 445,548,486.81 | 627,442,216.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,735,235,136.33 | 2,901,337,413.63 | 2,693,086,853.36 | 2,544,998,012.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,087,588,486 | 1,087,588,486 | 1,087,588,486 | 1,087,588,486 |
| 资本公积 | 472,366,560.81 | 472,615,899.61 | 472,987,173.09 | 472,987,173.09 |
| 减:库存股 | 99,998,598.94 | 99,998,598.94 | 99,998,598.94 | - |
| 其他综合收益 | 21,485,941.53 | 23,459,734.03 | 22,587,971.08 | 21,274,008.2 |
| 盈余公积 | 12,836,903.17 | 12,836,903.17 | 12,836,903.17 | 12,836,903.17 |
| 未分配利润 | 609,844,393.66 | 786,504,934.7 | 838,553,255.48 | 875,214,882.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,104,123,686.23 | 2,283,007,358.57 | 2,334,555,189.88 | 2,469,901,453.15 |
| 少数股东权益 | 49,918,484.28 | 69,222,085.49 | 89,541,154.23 | 102,507,867.33 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,154,042,170.51 | 2,352,229,444.06 | 2,424,096,344.11 | 2,572,409,320.48 |
| 负债和股东权益合计 | 4,889,277,306.84 | 5,253,566,857.69 | 5,117,183,197.47 | 5,117,407,332.82 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |